攜程數據:內地入境航班周末搜索量按周升92%
內地上周五(11日)宣布進一步優化防控工作的20條措施,包括密切接觸者及入境人員的集中隔離及居家隔離由「7+3」改為「5+3」,以及取消入境航班熔斷機制等。
攜程集團(09961.HK)旗下攜程旅行(Ctrip)平台上搜索量數據顯示,與上周同期(11月4至6日)比較,內地入境航班機票搜索量按周增長92%,前五個搜索入境中國的目的地及相應增長分別有香港、美國、日本、澳洲及新加坡。
內地出境航班機票搜索量按周增長46%,前五個內地搜索出境的目的地及相應增長分別有美國、日本、澳門、泰國及澳洲。
訂單數據方面,內地入境機票訂單量按周增長27%,前五入境目的地及相應增長分別有香港、南韓、新加坡、日本及美國。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.